Market Overview

Citigroup Upgrades Acorda Therapeutics, Inc. to Buy, Raises PT to $33.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ACOR

DateFirmActionFromTo
Jul 2017JefferiesInitiates Coverage OnHold
Mar 2017Janney CapitalUpgradesNeutralBuy
Feb 2017Goldman SachsUpgradesSellNeutral

View More Analyst Ratings for ACOR
View the Latest Analyst Ratings

Posted-In: News Upgrades Analyst Ratings

 

Related Articles (ACOR)